source
- Grail’s Galleri multi-cancer early detection trial misses primary endpoint, but oncologists note promising signalsThe first randomized trial of a multi-cancer early detection test enrolled about 143,000 English adults aged 50 to 77. Participants were randomly assigned to receive either standard care or the Gal…
- Promising pancreatic cancer drug daraxonrasib shows near-double survival, patients await expanded accessAmy Johnston, diagnosed with pancreatic cancer last year, has undergone chemotherapy and surgery and is now in a clinical trial that hopes to delay disease progression. She expects results by the e…